VTRS
Viatris Inc.$15.88-2.16% 1D· price as of Jun 30, 8:32 PM+74.12% over 1Y
Compare:VTRS
Mkt Cap
$18.5B
P/E
—
Fwd P/E
6.0×
PEG
0.15
P/B
1.3×
P/S
1.3×
EV/EBITDA
7.4×
Beta
0.90
Div Yield
3.0%
Payout
960.0%
ROE
-2.0%
Net Margin
-2.0%
Short % Flt
3.9%
Inst. Own
88.0%
52-wk low $8.63$15.8852-wk high $17.53
+84.0% above low-9.4% from high
Seasonality — avg monthly return
Strongest Dec 8.1% · weakest Feb -7.4%Jan
+2.5
Feb
-7.4
Mar
-6.9
Apr
-1.5
May
+6.0
Jun
-1.7
Jul
+1.6
Aug
+5.1
Sep
-7.3
Oct
+2.4
Nov
+4.1
Dec
+8.1
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Viatris Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
VTRS — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
31 / 100
Below average
ROIC0.7%
0
ROE-23.9%
0
Gross margin35.1%
0
Operating margin1.8%
0
FCF yield9.7%
83
Net debt / EBITDAnet cash
100
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.